Functionality of the B.44 drug programme “Treatment of Patients with Severe Asthma” in 2025 from the perspective of medical centres
Marek Kulus, Karina Jahnz‐Różyk, Radosław Gawlik, Maciej Kupczyk et autres
pl, us, bg, ie (code pays fourni par la source)